Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 10 1997, 2623-2627, Vol 35, No. 10
S Zou
This report describes a quick genetic approach to the screening of
influenza virus variants. Multiplex reverse transcription (MRT) and
multiplex PCR (MPCR) were used to amplify and differentiate the
hemagglutinin (HA) genes of different types and subtypes of influenza
viruses. Heteroduplex mobility assay (HMA) was then used to differentiate
strains within the same type and subtype. Three primers complementary to
the consensus 3' termini of viral genomic RNA segments of human influenza
virus types A, B, and C were used in a single MRT reaction to prime the
synthesis of cDNA of all the viral genome segments. The cDNA was then
amplified in an MPCR containing primers for the HA genes of the H1 and H3
subtypes of type A, the HA gene of type B, and the counterpart of type C
virus. Amplicons of the different types and subtypes differ in size, thus
allowing typing and subtyping. The regions amplified cover most of the HA1
portion of the HA genes and therefore amplicons of variants identified by
the described HMA can be sequenced directly. In the HMA, the amplicon of an
individual strain was mixed with that of a reference strain and
heteroduplexes derived from mismatches migrated more slowly than
homoduplexes of the same size in electrophoresis, with the mobility shift
pattern indicating the divergence of amplicons. The whole process from
viral RNA extraction to HMA can be completed within 2 days and thus
provides a quick screening before further analysis by hemagglutination
inhibition testing and sequencing. In addition, all segments of the viral
genome can be amplified from a single MRT reaction, which can yield
valuable sources of products for future genetic analyses. This method
should facilitate genetic screening and characterization of influenza virus
variants.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
A practical approach to genetic screening for influenza virus variants
Bureau of Microbiology, Laboratory Centre for Disease Control, Tunney's Pasture, Ottawa, Ontario, Canada. shimian_zou@inet.hwc.ca
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|